Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 6712529, 8 pages
http://dx.doi.org/10.1155/2016/6712529
Research Article

Genetic Analysis of the Atrial Natriuretic Peptide Gene Polymorphisms among Essential Hypertensive Patients in Malaysia

Genetic Research Group, Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia

Received 7 March 2016; Revised 26 April 2016; Accepted 4 May 2016

Academic Editor: Asude A. Durmaz

Copyright © 2016 Nooshin Ghodsian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Research for Universal Health Coverage: World Health Report, World Health Organization, Geneva, Switzerland, 2013.
  2. M. Ezzati, S. Oza, G. Danaei, and C. J. L. Murray, “Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States,” Circulation, vol. 117, no. 7, pp. 905–914, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. T. P. Singh, M. Rohit, A. Grover, S. Malhotra, and R. Vijayvergiya, “A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension,” American Heart Journal, vol. 151, no. 4, pp. 851.e1–851.e5, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. V. Chobanian, G. L. Bakris, H. R. Black et al., “Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure,” Hypertension, vol. 42, no. 6, pp. 1206–1252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Conen, P. M. Ridker, S. Mora, J. E. Buring, and R. J. Glynn, “Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study,” European Heart Journal, vol. 28, no. 23, pp. 2937–2943, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. R. Banegas, E. López-García, A. Graciani et al., “Relationship between obesity, hypertension and diabetes, and health-related quality of life among the elderly,” European Journal of Cardiovascular Prevention & Rehabilitation, vol. 14, no. 3, pp. 456–462, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. P. Lifton, A. G. Gharavi, and D. S. Geller, “Molecular mechanisms of human hypertension,” Cell, vol. 104, no. 4, pp. 545–556, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. D. S. Timberlake, D. T. O'Connor, and R. J. Parmer, “Molecular genetics of essential hypertension: recent results and emerging strategies,” Current Opinion in Nephrology and Hypertension, vol. 10, no. 1, pp. 71–79, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Cambien and L. Tiret, “Genetics of cardiovascular diseases: from single mutations to the whole genome,” Circulation, vol. 116, no. 15, pp. 1714–1724, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. D. L. Vesely, “Natriuretic peptides and acute renal failure,” American Journal of Physiology—Renal Physiology, vol. 285, no. 2, pp. F167–F177, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Yan, F. Wu, J. Morser, and Q. Wu, “Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 15, pp. 8525–8529, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Y. W. Lee and J. C. Burnett Jr., “Natriuretic peptides and therapeutic applications,” Heart Failure Reviews, vol. 12, no. 2, pp. 131–142, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. R. Dietz, “Mechanisms of atrial natriuretic peptide secretion from the atrium,” Cardiovascular Research, vol. 68, no. 1, pp. 8–17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Lucarelli, M. Iacoviello, P. Dessì-Fulgheri et al., “Peptidi natriuretici e ipertensione arteriosa essenziale,” Italian Heart Journal, Supplement, vol. 3, no. 11, pp. 1085–1091, 2002. View at Google Scholar
  15. A. I. Lynch, S. A. Claas, and D. K. Arnett, “A review of the role of atrial natriuretic peptide gene polymorphisms in hypertension and its sequelae,” Current Hypertension Reports, vol. 11, no. 1, pp. 35–42, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. D. R. Rutledge, Y. Sun, and E. A. Ross, “Polymorphisms within the atrial natriuretic peptide gene in essential hypertension,” Journal of Hypertension, vol. 13, no. 9, pp. 953–955, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Rampal, S. Rampal, M. Z. Azhar, and A. R. Rahman, “Prevalence, awareness, treatment and control of hypertension in Malaysia: a national study of 16,440 subjects,” Public Health, vol. 122, no. 1, pp. 11–18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Camm, “Medical management of atrial fibrillation: state of the art,” Journal of Cardiovascular Electrophysiology, vol. 17, supplement 2, pp. S2–S6, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Bansal, To study the prevalence of asymptomatic coronary artery disease in type 2 diabetes mellitus in KLES hospital and MRC, Belgaum-one year cross sectional study, 2008.
  20. W. C. S. Swee, T. G. Poh, T. S. Yean et al., “Relationship between body composition and bone mineral density in healthy postmenopausal Chinese women in Malaysia,” Jurnal Sains Kesihatan Malaysia, vol. 5, no. 2, pp. 29–38, 2007. View at Google Scholar
  21. W.-C. Hsueh, B. D. Mitchell, J. L. Schneider et al., “QTL influencing blood pressure maps to the region of PPH1 on chromosome 2q31-34 in Old Order Amish,” Circulation, vol. 101, no. 24, pp. 2810–2816, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. S. B. Harrap, A. D. Cumming, D. L. Davies et al., “Glomerular hyperfiltration, high renin, and low-extracellular volume in high blood pressure,” Hypertension, vol. 35, no. 4, pp. 952–957, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. A. F. Dominiczak, D. C. Negrin, J. S. Clark, M. J. Brosnan, M. W. McBride, and M. Y. Alexander, “Genes and hypertension: from gene mapping in experimental models to vascular gene transfer strategies,” Hypertension, vol. 35, no. 1, pp. 164–172, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. P. M. McKie, T. Ichiki, and J. C. Burnett Jr., “M-atrial natriuretic peptide: a novel antihypertensive protein therapy,” Current Hypertension Reports, vol. 14, no. 1, pp. 62–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Hu, X. Xu, X. Liang et al., “Associations of plasma atrial natriuretic peptide and electrolyte levels with essential hypertension,” Experimental and Therapeutic Medicine, vol. 5, no. 5, pp. 1439–1443, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Kato, T. Sugiyama, H. Morita et al., “Genetic analysis of the atrial natriuretic peptide gene in essential hypertension,” Clinical Science, vol. 98, no. 3, pp. 251–258, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Rubattu, G. Bigatti, A. Evangelista et al., “Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension,” Journal of the American College of Cardiology, vol. 48, no. 3, pp. 499–505, 2006. View at Publisher · View at Google Scholar · View at Scopus